PubMed

Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration.

Kahler KH, Rajan M, Rhoads GG, Safford MM, Demissie K, Lu SE, Pogach LM.

Diabetes Care. 2007 Jul;30(7):1689-93. Epub 2007 Apr 17.PMID: 17440170 [PubMed - indexed for MEDLINE]Related articlesFree article

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

Johnson JA, Majumdar SR, Simpson SH, Toth EL.

Diabetes Care. 2002 Dec;25(12):2244-8.PMID: 12453968 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis.

Asche CV, McAdam-Marx C, Shane-McWhorter L, Sheng X, Plauschinat CA.

Drugs Aging. 2008;25(7):611-22.PMID: 18582148 [PubMed - indexed for MEDLINE]Related articles

Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus.

Gosmanova EO, Canada RB, Mangold TA, Rawls WN, Wall BM.

Am J Med Sci. 2008 Sep;336(3):241-7.PMID: 18794619 [PubMed - indexed for MEDLINE]Related articles

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA.

Diabetes Care. 2006 Feb;29(2):254-8.PMID: 16443869 [PubMed - indexed for MEDLINE]Related articlesFree article

Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.

Riedel AA, Heien H, Wogen J, Plauschinat CA.

Am J Manag Care. 2007 Aug;13(8):457-63.PMID: 17685826 [PubMed - indexed for MEDLINE]Related articlesFree article

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.

Aquilante CL, Zhang W, McCollum M.

Curr Med Res Opin. 2007 Mar;23(3):489-94.PMID: 17355730 [PubMed - indexed for MEDLINE]Related articles

Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes.

Ceriello A, Johns D, Widel M, Eckland DJ, Gilmore KJ, Tan MH.

Diabetes Care. 2005 Feb;28(2):266-72. Erratum in: Diabetes Care. 2005 May;28(5):1272. PMID: 15677777 [PubMed - indexed for MEDLINE]Related articlesFree article

The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.

Johannes CB, Koro CE, Quinn SG, Cutone JA, Seeger JD.

Pharmacoepidemiol Drug Saf. 2007 May;16(5):504-12.PMID: 17245800 [PubMed - indexed for MEDLINE]Related articles

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure.

Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA.

Diabetes Care. 2005 Oct;28(10):2345-51.PMID: 16186261 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program.

Lawrence DB, Ragucci KR, Long LB, Parris BS, Helfer LA.

J Manag Care Pharm. 2006 Jul-Aug;12(6):466-71.PMID: 16925454 [PubMed - indexed for MEDLINE]Related articlesFree article

Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus.

Eurich DT, Simpson SH, Majumdar SR, Johnson JA.

Pharmacotherapy. 2005 Jun;25(6):810-6.PMID: 15927899 [PubMed - indexed for MEDLINE]Related articles

The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy.

McAlister FA, Eurich DT, Majumdar SR, Johnson JA.

Eur J Heart Fail. 2008 Jul;10(7):703-8. Epub 2008 Jun 19.PMID: 18571471 [PubMed - indexed for MEDLINE]Related articles

Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study.

Gulliford M, Latinovic R.

Diabetes Metab Res Rev. 2004 May-Jun;20(3):239-45.PMID: 15133756 [PubMed - indexed for MEDLINE]Related articles

Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.

Lewin A, Lipetz R, Wu J, Schwartz S.

Clin Ther. 2007 May;29(5):844-55.PMID: 17697903 [PubMed - indexed for MEDLINE]Related articles

Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.

Vanderpoel DR, Hussein MA, Watson-Heidari T, Perry A.

Clin Ther. 2004 Dec;26(12):2066-75.PMID: 15823770 [PubMed - indexed for MEDLINE]Related articles

Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.

Riedel AA, Heien H, Wogen J, Plauschinat CA.

Pharmacotherapy. 2007 Aug;27(8):1102-10.PMID: 17655510 [PubMed - indexed for MEDLINE]Related articles

Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies.

Rao AD, Kuhadiya N, Reynolds K, Fonseca VA.

Diabetes Care. 2008 Aug;31(8):1672-8. Epub 2008 May 5.PMID: 18458139 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes.

Johnson JA, Simpson SH, Toth EL, Majumdar SR.

Diabet Med. 2005 Apr;22(4):497-502.PMID: 15787679 [PubMed - indexed for MEDLINE]Related articles

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.

Evans JM, Ogston SA, Emslie-Smith A, Morris AD.

Diabetologia. 2006 May;49(5):930-6. Epub 2006 Mar 9.PMID: 16525843 [PubMed - indexed for MEDLINE]Related articles